Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Invest Surg ; 35(11-12): 1836-1840, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36202396

RESUMO

INTRODUCTION: Splenic abscess secondary to endocarditis is a rare complication with high mortality. The treatment modality, splenectomy versus percutaneous drainage, and the best time, before or after valve replacement, are controversial. In the literature, there are only a few small case series about the subject. The objective of this study is to analyze the experience of a referral center in treating such condition. METHODS: Patients with splenic abscesses due to endocarditis from 2006 to 2020 were retrospectively analyzed. RESULTS: Thirteen patients (mean age 46 years old, 69% male) were identified. Eight patients (62%) had at least 2 comorbidities and 5 (38%) had a history of cardiac surgery. The diagnosis was incidental in 6 (46%). The mean time of abscess diagnosis after endocarditis definition was 14 days. Six patients (46%) had at least two organ dysfunctions. The median APACHE II score was 12 overall, and 24.5 in patients who died. Six patients (46%) had a valve replacement, and in two the abscess was diagnosed postoperatively. Of the other four patients, splenectomy was performed before the cardiac operation in three and at the same time in one. Splenectomy was performed immediately in 9 (69%) patients while three patients had percutaneous drainage (23%), one of which underwent splenectomy due to drainage failure. Exclusive antibiotic treatment was performed on only one patient. The median length of hospitalization was 24 days and mortality was 46%. CONCLUSION: Splenic abscess due to endocarditis is a life-threatening condition with controversial treatment that results in a prolonged length of stay and high mortality.


Assuntos
Abscesso Abdominal , Endocardite , Esplenopatias , Abscesso/etiologia , Abscesso/cirurgia , Antibacterianos/uso terapêutico , Brasil/epidemiologia , Endocardite/complicações , Endocardite/diagnóstico , Endocardite/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Raras/complicações , Doenças Raras/tratamento farmacológico , Estudos Retrospectivos , Esplenopatias/etiologia , Esplenopatias/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...